Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 03-Sep-24 4:21 PM View:  | Valeant Pharmaceuticals Int... (BHC) | 30-Aug-24 | Payment of Exercise | 14,683 | $5.93 | $87,070.20 | (1%) 1.37M to 1.35M | |
| 04-Mar-24 4:19 PM View: | Valeant Pharmaceuticals Int... (BHC) | 01-Mar-24 | Payment of Exercise | 116,982 | $9.89 | $1,156,950.00 | (8%) 1.49M to 1.37M | |
| 04-Mar-24 4:19 PM View: | Valeant Pharmaceuticals Int... (BHC) | 29-Feb-24 | Grant | 519,328 | -- | -- | 54% 967.01K to 1.49M | |
| 05-Sep-23 5:09 PM View: | Valeant Pharmaceuticals Int... (BHC) | 01-Sep-23 | Payment of Exercise | 14,111 | $8.46 | $119,379.00 | (1%) 981.12K to 967.01K | |
| 06-Mar-23 4:49 PM View: | Valeant Pharmaceuticals Int... (BHC) | 03-Mar-23 | Payment of Exercise | 10,175 | $9.16 | $93,203.00 | (1%) 991.3K to 981.12K | |
| 06-Mar-23 4:49 PM View: | Valeant Pharmaceuticals Int... (BHC) | 02-Mar-23 | Grant | 523,155 | -- | -- | 108% 485.57K to 1.01M | |
| 06-Mar-23 4:49 PM View: | Valeant Pharmaceuticals Int... (BHC) | 02-Mar-23 | Payment of Exercise | 17,432 | $9.25 | $161,246.00 | (2%) 1.01M to 991.3K | |
| 01-Mar-23 5:43 PM View: | Valeant Pharmaceuticals Int... (BHC) | 27-Feb-23 | Payment of Exercise | 6,327 | $9.57 | $60,549.40 | (1%) 491.9K to 485.57K | |
| 02-Sep-22 4:35 PM View: | Valeant Pharmaceuticals Int... (BHC) | 01-Sep-22 | Disposition | 15,389 | $6.59 | $101,414.00 | (3%) 507.29K to 491.9K | |
| 12-May-22 8:44 PM View: | Valeant Pharmaceuticals Int... (BHC) | 10-May-22 | Option Exercise | 32,022 | -- | -- | 7% 475.27K to 507.29K | |
| 07-Mar-22 5:30 PM View: | Valeant Pharmaceuticals Int... (BHC) | 03-Mar-22 | Payment of Exercise | 5,564 | $23.61 | $131,366.00 | (1%) 480.83K to 475.27K | |
| 04-Mar-22 4:50 PM View: | Valeant Pharmaceuticals Int... (BHC) | 02-Mar-22 | Grant | 152,690 | -- | -- | 47% 328.14K to 480.83K | |
| 02-Mar-22 9:12 PM View: | Valeant Pharmaceuticals Int... (BHC) | 27-Feb-22 | Payment of Exercise | 11,184 | $24.35 | $272,330.00 | (3%) 339.32K to 328.14K | |
| 02-Mar-22 9:12 PM View: | Valeant Pharmaceuticals Int... (BHC) | 27-Feb-22 | Option Exercise | 24,292 | -- | -- | 8% 315.03K to 339.32K | |
| 02-Mar-22 9:12 PM View: | Valeant Pharmaceuticals Int... (BHC) | 26-Feb-22 | Payment of Exercise | 2,192 | $24.35 | $53,375.20 | (< 1%) 332.74K to 330.54K | |
| 30-Dec-21 7:29 PM View: | Valeant Pharmaceuticals Int... (BHC) | 15-Dec-21 | Payment of Exercise | 3,461 | $24.49 | $84,759.90 | (1%) 320.69K to 317.23K | |
| 10-Mar-21 8:49 PM View: | Valeant Pharmaceuticals Int... (BHC) | 10-Mar-21 | Payment of Exercise | 17,480 | $32.97 | $576,316.00 | (7%) 247.91K to 230.43K | |
| 10-Mar-21 8:49 PM View: | Valeant Pharmaceuticals Int... (BHC) | 08-Mar-21 | Grant | 28,144 | -- | -- | 13% 210.6K to 238.75K | |
| 10-Mar-21 8:49 PM View: | Valeant Pharmaceuticals Int... (BHC) | 08-Mar-21 | Option Exercise | 9,161 | -- | -- | 4% 238.75K to 247.91K | |
| 05-Mar-21 5:52 PM View: | Valeant Pharmaceuticals Int... (BHC) | 03-Mar-21 | Grant | 32,626 | -- | -- | 18% 177.97K to 210.6K | |
| 03-Mar-21 4:30 PM View: | Valeant Pharmaceuticals Int... (BHC) | 01-Mar-21 | Payment of Exercise | 5,436 | $31.42 | $170,799.00 | (3%) 183.41K to 177.97K | |
| 17-Dec-20 7:29 PM View: | Valeant Pharmaceuticals Int... (BHC) | 15-Dec-20 | Payment of Exercise | 3,224 | $20.61 | $66,446.60 | (2%) 186.63K to 183.41K | (6%) |
| 11-Mar-20 8:54 PM View: | Valeant Pharmaceuticals Int... (BHC) | 09-Mar-20 | Payment of Exercise | 2,734 | $20.96 | $57,304.60 | (1%) 189.37K to 186.63K | (4%) |
| 03-Mar-20 4:54 PM View: | Valeant Pharmaceuticals Int... (BHC) | 28-Feb-20 | Payment of Exercise | 2,796 | $24.44 | $68,334.20 | (1%) 192.16K to 189.37K | |
| 28-Feb-20 7:22 PM View: | Valeant Pharmaceuticals Int... (BHC) | 26-Feb-20 | Grant | 19,449 | -- | -- | 11% 172.72K to 192.16K | |
| 21-Feb-20 9:54 PM View: | Valeant Pharmaceuticals Int... (BHC) | 20-Feb-20 | Payment of Exercise | 9,866 | $26.46 | $261,054.00 | (5%) 182.58K to 172.72K | |
| 21-Feb-20 9:54 PM View: | Valeant Pharmaceuticals Int... (BHC) | 19-Feb-20 | Grant | 21,133 | -- | -- | 13% 157.52K to 178.65K | |
| 21-Feb-20 9:54 PM View: | Valeant Pharmaceuticals Int... (BHC) | 19-Feb-20 | Option Exercise | 3,932 | -- | -- | 2% 178.65K to 182.58K | |
| 09-Jan-20 4:19 PM View: | Valeant Pharmaceuticals Int... (BHC) | 07-Jan-20 | Payment of Exercise | 1,827 | $29.42 | $53,750.30 | (1%) 159.34K to 157.52K | |
| 17-Dec-19 7:20 PM View: | Valeant Pharmaceuticals Int... (BHC) | 16-Dec-19 | Payment of Exercise | 3,337 | $31.00 | $103,447.00 | (2%) 162.68K to 159.34K | |
| 21-Aug-19 4:19 PM View: | Valeant Pharmaceuticals Int... (BHC) | 19-Aug-19 | Payment of Exercise | 8,362 | $21.30 | $178,111.00 | (5%) 171.04K to 162.68K | (2%) |
| 12-Mar-19 4:25 PM View: | Valeant Pharmaceuticals Int... (BHC) | 08-Mar-19 | Payment of Exercise | 2,907 | $23.56 | $68,488.90 | (2%) 173.95K to 171.04K | < 1% |
| 01-Mar-19 5:01 PM View: | Valeant Pharmaceuticals Int... (BHC) | 27-Feb-19 | Grant | 21,310 | -- | -- | 14% 152.64K to 173.95K | |
| 10-Jan-19 4:04 PM View: | Valeant Pharmaceuticals Int... (BHC) | 08-Jan-19 | Payment of Exercise | 1,722 | $21.25 | $36,592.50 | (1%) 154.36K to 152.64K | (12%) |
| 18-Dec-18 4:22 PM View: | Valeant Pharmaceuticals Int... (BHC) | 14-Dec-18 | Grant | 25,440 | -- | -- | 25% 103.48K to 128.92K | |
| 18-Dec-18 4:22 PM View: | Valeant Pharmaceuticals Int... (BHC) | 14-Dec-18 | Market Purchase | 25,440 | $22.96 | $584,018.00 | 20% 128.92K to 154.36K | 3% |
| 22-Aug-18 4:30 PM View: | Valeant Pharmaceuticals Int... (BHC) | 20-Aug-18 | Payment of Exercise | 5,501 | $21.69 | $119,317.00 | (5%) 110.09K to 104.58K | (9%) |
| 09-Mar-18 8:56 PM View: | Valeant Pharmaceuticals Int... (BHC) | 07-Mar-18 | Grant | 22,162 | -- | -- | 25% 87.92K to 110.09K | |
| 09-Jan-18 3:27 PM View: | Valeant Pharmaceuticals Int... (BHC) | 08-Jan-18 | Payment of Exercise | 1,557 | $23.85 | $37,134.40 | (2%) 89.19K to 87.63K | < 1% |
| 22-Aug-17 4:37 PM View: | Valeant Pharmaceuticals Int... (BHC) | 18-Aug-17 | Payment of Exercise | 5,687 | $14.15 | $80,471.00 | (6%) 94.88K to 89.19K | (67%) |
| 11-May-17 4:56 PM View: | Valeant Pharmaceuticals Int... (BHC) | 10-May-17 | Payment of Exercise | 3,274 | $9.71 | $31,790.50 | (3%) 98.15K to 94.88K | |
| 30-Mar-17 5:30 PM View: | Valeant Pharmaceuticals Int... (BHC) | 28-Mar-17 | Grant | 63,742 | -- | -- | 185% 34.41K to 98.15K | |
| 10-Jan-17 7:12 PM View: | Valeant Pharmaceuticals Int... (BHC) | 06-Jan-17 | Grant | 12,287 | -- | -- | 56% 22.12K to 34.41K |